Medical Innovation Ventures (Mediven®) is a fast-growing diagnostics company based in Malaysia developing the GenoAmp® and ProDetect® series of products. Mediven collaborates closely with research institutions locally and abroad with the hope to change the paradigm of personalized medicine. We tap on research and scientific expertise to constantly come up with innovative products for the localization of personalized health through diagnostics and early detection. Mediven uses the wealth of genomic information generated on pathogens acquired through the deployment in various localized populations to create diagnostic tools that aid in the early and fast detection of infectious diseases. Our products enable differentiated strategies for better health management.
Fast, Flexible, Convenient, and Highly informative are the characteristic features of Mediven’s proprietary products. Mediven also markets and distributes other products and offers custom services for the development of molecular diagnostics and point of care tests.
Mediven was honoured by Frost & Sullivan at the 12th annual Malaysia Excellence Awards on April 14, 2016, for the Entrepreneurial Company of the Year award.
To be the leading provider of diagnostics solutions for personalized health.
Provide fast, flexible, intelligent, and reliable diagnostic solutions to improve health.
Knowledgeable: Knowledgeable Our scientific experts possess in-depth know-how, knowledge and experience in technology platforms and diseases areas to develop innovative diagnostics solutions. Our business experts have the market knowledge and insights to develop and provide market access to those who need them most. It is a combination of these, which makes us a successful provider of diagnostic solutions to developing nations.
Innovative: We are innovative in working with our partners to improve and add value to their projects and with our customers to provide the best access possible to the diagnostic solutions they need.
Well-networked: We partner and collaborate with different disciplines and parties, be it from the government, academia, or industry, locally and internationally to achieve excellence in terms of science and market access.
Responsible: Instituting best practices, looking after the community and our conservation works are central to our efforts to being a responsible company. We have the ISO 13485, GDPMD and BioNexus marks of excellence.